Skip to search formSkip to main contentSkip to account menu

Dexamethasone Drug Implant [Ozurdex]

National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

Dexamethasone 0.7 MG Drug Implant [Ozurdex]
Drug ImplantOzurdex

Broader (1)

Ozurdex Drug Implant Product

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report
Background Dexamethasone intravitreal implants (0.7 mg) (Ozurdex®, Allergan Inc., Madison, NJ) are FDA approved for managing… 
2019
2019
Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
Purpose To compare the effect of adding a corticosteroid or switching to another anti-VEGF treatment in patients with exudative… 
2017
2017
Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber
Review
2016
Review
2016
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
PurposeTo review published data pertaining to the clinical experience with a dexamethasone intravitreal implant (Ozurdex®) with a… 
2016
2016
Long-Term Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Diabetic Macular Edema
Purpose To evaluate the long-term efficacy and safety of the dexamethasone intravitreal implant Ozurdex® in the treatment of… 
2016
2016
Long-Term Real-Life Efficacy and Safety of Repeated Ozurdex® Injections and Factors Associated with Macular Edema Resolution after Retinal Vein Occlusion: The REMIDO 2 Study
Purpose: The objective was to study long-term real-life efficacy and safety of repeated Ozurdex® injections and factors… 
2015
2015
Effect of Intravitreal Injection of Dexamethasone 0.7 mg (Ozurdex®) on Intraocular Pressure in Patients with Macular Edema
Background: To evaluate the effect of Ozurdex® on intraocular pressure in patients with macular edema alone (group 1) or… 
Highly Cited
2013
Highly Cited
2013
Zuverlässigkeit und Sicherheit von intravitrealen Ozurdex-Injektionen
ZusammenfassungHintergrundSeit Juli 2010 ist Ozurdex® in Deutschland für die Behandlung des Makulaödems (MÖ) von venösen… 
Review
2012
Review
2012
Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion
Purpose: To evaluate the effects of repeated intravitreal dexamethasone implant (IDI) (Ozurdex®) in eyes with macular edema (ME… 
2011
2011
SD-OCT Pattern of Retinal Venous Occlusion with Cystoid Macular Edema Treated with Ozurdex®
Purpose To report our experience with sustained-release dexamethasone 0.7 mg intravitreal implant (Ozurdex®; Allergan, Inc… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)